Havencrest Healthcare Partners, L.p. - Net Worth and Insider Trading

Havencrest Healthcare Partners, L.p. Net Worth

The estimated net worth of Havencrest Healthcare Partners, L.p. is at least $3 Million dollars as of 2024-12-27. Havencrest Healthcare Partners, L.p. is the 10% Owner of The Oncology Institute Inc and owns about 8,801,823 shares of The Oncology Institute Inc (TOI) stock worth over $3 Million. Details can be seen in Havencrest Healthcare Partners, L.p.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Havencrest Healthcare Partners, L.p. has not made any transactions after 2024-01-29 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Havencrest Healthcare Partners, L.p.

Havencrest Healthcare Partners, L.p. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Havencrest Healthcare Partners, L.p. owns 1 companies in total, including The Oncology Institute Inc (TOI) .

Click here to see the complete history of Havencrest Healthcare Partners, L.p.’s form 4 insider trades.

Insider Ownership Summary of Havencrest Healthcare Partners, L.p.

Ticker	Comapny	Transaction Date	Type of Owner
TOI	The Oncology Institute Inc	2024-01-29	10 percent owner

Havencrest Healthcare Partners, L.p. Latest Holdings Summary

Havencrest Healthcare Partners, L.p. currently owns a total of 1 stock. Havencrest Healthcare Partners, L.p. owns 8,801,823 shares of The Oncology Institute Inc (TOI) as of January 29, 2024, with a value of $3 Million.

Latest Holdings of Havencrest Healthcare Partners, L.p.

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
TOI	The Oncology Institute Inc	2024-01-29	8,801,823	0.32	2,785,777

Holding Weightings of Havencrest Healthcare Partners, L.p.

Havencrest Healthcare Partners, L.p. Form 4 Trading Tracker

According to the SEC Form 4 filings, Havencrest Healthcare Partners, L.p. has made a total of 24 transactions in The Oncology Institute Inc (TOI) over the past 5 years, including 0 buys and 24 sells. The most-recent trade in The Oncology Institute Inc is the sale of 8,637 shares on January 29, 2024, which brought Havencrest Healthcare Partners, L.p. around $18,310.

Insider Trading History of Havencrest Healthcare Partners, L.p.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Havencrest Healthcare Partners, L.p. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Havencrest Healthcare Partners, L.p. Ownership Network

Ownership Network List of Havencrest Healthcare Partners, L.p.

No Data

Ownership Network Relation of Havencrest Healthcare Partners, L.p.

Havencrest Healthcare Partners, L.p. Owned Company Details

What does The Oncology Institute Inc do?

Who are the key executives at The Oncology Institute Inc?

Havencrest Healthcare Partners, L.p. is the 10 percent owner of The Oncology Institute Inc. Other key executives at The Oncology Institute Inc include director & Chief Executive Officer Brad Hively , Chief Financial Officer & other: Principal Financial Officer Mihir Shah , and Chief Operating Officer Jeremy Castle .

The Oncology Institute Inc (TOI) Insider Trades Summary

Over the past 18 months, Havencrest Healthcare Partners, L.p. made 3 insider transaction in The Oncology Institute Inc (TOI) with a net sale of 80,000. Other recent insider transactions involving The Oncology Institute Inc (TOI) include a net purchase of 228,000 shares made by Brad Hively , a net purchase of 100,000 shares made by Mihir Shah ,

In summary, during the past 3 months, insiders sold 0 shares of The Oncology Institute Inc (TOI) in total and bought 300,000 shares, with a net purchase of 300,000 shares. During the past 18 months, 152,000 shares of The Oncology Institute Inc (TOI) were sold and 400,000 shares were bought by its insiders, resulting in a net purchase of 248,000 shares.

The Oncology Institute Inc (TOI)'s detailed insider trading history can be found in Insider Trading Tracker table.

The Oncology Institute Inc Insider Transactions

No Available Data

Havencrest Healthcare Partners, L.p. Mailing Address

Above is the net worth, insider trading, and ownership report for Havencrest Healthcare Partners, L.p.. You might contact Havencrest Healthcare Partners, L.p. via mailing address: 5221 N. O'connor Blvd., Suite 1200, Irving Tx 75039.

Discussions on Havencrest Healthcare Partners, L.p.

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.